相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cancer statistics, 2020
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2020)
Pembrolizumab in Recurrent Squamous Cell Carcinoma of the Vulva: Case Report and Review of the Literature
LisaB. E. Shields et al.
GYNECOLOGIC AND OBSTETRIC INVESTIGATION (2019)
PD-L1 and IDO expression in cervical and vulvar invasive and intraepithelial squamous neoplasias: implications for combination immunotherapy
Zachary Chinn et al.
HISTOPATHOLOGY (2019)
Reviewing vulvar Paget's disease molecular bases. Looking forward to personalized target therapies: a matter of CHANGE
Giulia Mantovani et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2019)
The prognostic value of p16 and p53 expression for survival after vulvar cancer: A systematic review and meta-analysis
Freja Laerke Sand et al.
GYNECOLOGIC ONCOLOGY (2019)
T-Cell-Inflamed Gene-Expression Profile, Programmed Death Ligand 1 Expression, and Tumor Mutational Burden Predict Efficacy in Patients Treated With Pembrolizumab Across 20 Cancers: KEYNOTE-028
Patrick A. Ott et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Does HPV status influence survival after vulvar cancer?
Christina Louise Rasmussen et al.
INTERNATIONAL JOURNAL OF CANCER (2018)
The role of bevacizumab on tumour angiogenesis and in the management of gynaecological cancers: A review
Dinesh Kumar Chellappan et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
Somatic mutation profiling of vulvar cancer: Exploring therapeutic targets
Sebastian Zieba et al.
GYNECOLOGIC ONCOLOGY (2018)
New therapeutic strategies to treat human cancers expressing mutant p53 proteins
Giovanni Blandino et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2018)
PD-L1 receptor expression in vulvar carcinomas is HPV-independent
M. Choschzick et al.
VIRCHOWS ARCHIV (2018)
Prevalence of human papillomavirus and its prognostic value in vulvar cancer: A systematic review and meta-analysis
Jianxin Zhang et al.
PLOS ONE (2018)
Identification of molecular targets in vulvar cancers
Marguerite L. Palisoul et al.
GYNECOLOGIC ONCOLOGY (2017)
Analysis of full coding sequence of the TP53 gene in invasive vulvar cancers: Implications for therapy
Karl Kashofer et al.
GYNECOLOGIC ONCOLOGY (2017)
Systematic Review and Network Meta-Analysis of Bevacizumab Plus First-Line Topotecan-Paclitaxel or Cisplatin-Paclitaxel Versus Non-YBevacizumab-Containing Therapies in Persistent, Recurrent, or Metastatic Cervical Cancer
Virginia M. Rosen et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2017)
PD-L1 expression on immune cells is a favorable prognostic factor for vulvar squamous cell carcinoma patients
Jacek J. Sznurkowski et al.
ONCOTARGET (2017)
Tumoral PD-L1 expression defines a subgroup of poor-prognosis vulvar carcinomas with non-viral etiology
Thomas Hecking et al.
ONCOTARGET (2017)
Local immune response depends on p16INK4a status of primary tumor in vulvar squamous cell carcinoma
Jacek J. Sznurkowski et al.
ONCOTARGET (2017)
Prognostic value of PD-L1 expression in tumor infiltrating immune cells in cancers: A meta-analysis
Tiancheng Zhao et al.
PLOS ONE (2017)
Genomic Characterization of Vulvar (Pre) cancers Identifies Distinct Molecular Subtypes with Prognostic Significance
Linda S. Nooij et al.
CLINICAL CANCER RESEARCH (2017)
Vulvar Squamous Cell Carcinoma (VSCC) as Two Diseases: HPV Status Identifies Distinct Mutational Profiles Including Oncogenic Fibroblast Growth Factor Receptor 3
Johanne I. Weberpals et al.
CLINICAL CANCER RESEARCH (2017)
The forgotten woman's cancer: vulvar squamous cell carcinoma (VSCC) and a targeted approach to therapy
A. A. Clancy et al.
ANNALS OF ONCOLOGY (2016)
Prognostic Value of Overexpressed p16INK4a in Vulvar Cancer: A Meta-Analysis
Hanyu Cao et al.
PLOS ONE (2016)
Genetic Basis for PD-L1 Expression in Squamous Cell Carcinomas of the Cervix and Vulva
Brooke E. Howitt et al.
JAMA ONCOLOGY (2016)
Genetic and epigenetic changes in vulvar squamous cell carcinoma and its precursor lesions: A review of the current literature
Marjolijn D. Trietsch et al.
GYNECOLOGIC ONCOLOGY (2015)
Subtypes of cytotoxic lymphocytes and natural killer cells infiltrating cancer nests correlate with prognosis in patients with vulvar squamous cell carcinoma
Jacek Jan Sznurkowski et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2014)
Systemic therapy in squamous cell carcinoma of the vulva: Current status and future directions
Clare J. Reade et al.
GYNECOLOGIC ONCOLOGY (2014)
Fascin and cyclin D1 immunoreactivity in non-neoplastic vulvar squamous epithelium, vulvar intraepithelial neoplasia and invasive squamous carcinoma: correlation with Ki67 and p16 protein expression
C. J. R. Stewart et al.
JOURNAL OF CLINICAL PATHOLOGY (2014)
Improved Survival with Bevacizumab in Advanced Cervical Cancer
Krishnansu S. Tewari et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Primary Tumor Vascularity, HIF-1α and VEGF expression in vulvar squamous cell carcinomas: their relationships with clinicopathological characteristics and prognostic impact
Hari Prasad Dhaka et al.
BMC CANCER (2013)
Pathways of vulvar intraepithelial neoplasia and squamous cell carcinoma
Marta del Pino et al.
HISTOPATHOLOGY (2013)
Expression of Endogenous Hypoxia Markers in Vulvar Squamous Cell Carcinoma
Yu-Zhu Li et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2012)
Clinico-pathological and biological prognostic variables in squamous cell carcinoma of the vulva
Angiolo Gadducci et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2012)
Status of cellular immunity lacks prognostic significance in vulvar squamous carcinoma
R. A. de Jong et al.
GYNECOLOGIC ONCOLOGY (2012)
Phase II trial of erlotinib in women with squamous cell carcinoma of the vulva
N. S. Horowitz et al.
GYNECOLOGIC ONCOLOGY (2012)
Role of cyclin D1 amplification and expression in vulvar carcinomas
Matthias Choschzick et al.
HUMAN PATHOLOGY (2012)
EGFR gene copy number increase in vulvar carcinomas is linked with poor clinical outcome
L. Woelber et al.
JOURNAL OF CLINICAL PATHOLOGY (2012)
Expression of indoleamine 2,3-dioxygenase predicts shorter survival in patients with vulvar squamous cell carcinoma (vSCC) not influencing on the recruitment of FOXP3-expressing regulatory T cells in cancer nests
Jacek J. Sznurkowski et al.
GYNECOLOGIC ONCOLOGY (2011)
Cytoplasmic expression of oestrogen receptor beta (ERß) as a prognostic factor in vulvar squamous cell carcinoma in elderly women
Gian F. Zannoni et al.
HISTOPATHOLOGY (2011)
Changes in the expression of oestrogen receptors and E-cadherin as molecular markers of progression from normal epithelium to invasive cancer in elderly patients with vulvar squamous cell carcinoma
Gian F. Zannoni et al.
HISTOPATHOLOGY (2011)
Prognostic Significance of CD4+ and CD8+ T Cell Infiltration Within Cancer Cell Nests in Vulvar Squamous Cell Carcinoma
Jacek Jan Sznurkowski et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2011)
A review of molecular pathological markers in vulvar carcinoma: lack of application in clinical practice
S. Knopp et al.
JOURNAL OF CLINICAL PATHOLOGY (2009)
Decreased survival in EGFR gene amplified vulvar carcinoma
Whitfield B. Growdon et al.
GYNECOLOGIC ONCOLOGY (2008)
Recurrent metastatic vulvar carcinoma treated with cisplatin plus cetuximab
S. D. Richard et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2008)
Epidermal growth factor receptor and cancer: control of oncogenic signalling by endocytosis
Michael Vibo Grandal et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2008)
Drug therapy: EGFR antagonists in cancer treatment
Fortunato Ciardiello et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Differential expression of oestrogen receptor isoforms and androgen receptor in the normal vulva and vagina compared with vulval lichen sclerosus and chronic vaginitis
A. H. Taylor et al.
BRITISH JOURNAL OF DERMATOLOGY (2008)
Epidermal growth factor receptor is involved in the development of an invasive phenotype in Vulvar squamous lesions, but is not related to MIB-1 immunoreactivity
Hermann Brustmann
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY (2007)
The role of anglogenesis and COX-2 expression in the evolution of vulvar lichen sclerosus to squamous cell carcinoma of the vulva
Maria Rosaria Raspollini et al.
GYNECOLOGIC ONCOLOGY (2007)
Increased angiogenesis is associated with poor prognosis of squamous cell carcinoma of the vulva
Veera V. Nayha et al.
ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA (2007)
EGFR expression is associated with groin node metastases in vulvar cancer, but does not improve their prediction
M. H. M. Oonk et al.
GYNECOLOGIC ONCOLOGY (2007)
Treatment of squamous cell vulvar cancer with the anti-EGFR tyrosine kinase inhibitor Tarceva
Alexander Olawaiye et al.
GYNECOLOGIC ONCOLOGY (2007)
Vulvar squamous cell carcinoma is a multifactorial disease following two separate and independent pathways
IAM van der Avoort et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY (2006)
Role of cell-cycle regulatory proteins in gynecological cancer
K Milde-Langosch et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2003)
The role of angiogenesis in vulvar cancer, vulvar intraepithelial neoplasia, and vulvar lichen sclerosus as determined by microvessel density analysis
J Saravanamuthu et al.
GYNECOLOGIC ONCOLOGY (2003)
Cyclin D1 and retinoblastoma protein in vulvar cancer and adjacent lesions
KJ Rolfe et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2001)
分享论文
